NL8401221A - Analytische toepassing van fagocyt-cellijnen. - Google Patents

Analytische toepassing van fagocyt-cellijnen. Download PDF

Info

Publication number
NL8401221A
NL8401221A NL8401221A NL8401221A NL8401221A NL 8401221 A NL8401221 A NL 8401221A NL 8401221 A NL8401221 A NL 8401221A NL 8401221 A NL8401221 A NL 8401221A NL 8401221 A NL8401221 A NL 8401221A
Authority
NL
Netherlands
Prior art keywords
cells
phagocyte
analyzed
stimulator
chemiluminescence
Prior art date
Application number
NL8401221A
Other languages
English (en)
Dutch (nl)
Original Assignee
Innovi Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovi Nv filed Critical Innovi Nv
Priority to NL8401221A priority Critical patent/NL8401221A/nl
Priority to IL74904A priority patent/IL74904A/xx
Priority to US06/723,100 priority patent/US4737455A/en
Priority to DE8585104572T priority patent/DE3579731D1/de
Priority to AT85104572T priority patent/ATE56750T1/de
Priority to EP85104572A priority patent/EP0159653B1/de
Priority to JP60082106A priority patent/JPS60256377A/ja
Publication of NL8401221A publication Critical patent/NL8401221A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL8401221A 1984-04-16 1984-04-16 Analytische toepassing van fagocyt-cellijnen. NL8401221A (nl)

Priority Applications (7)

Application Number Priority Date Filing Date Title
NL8401221A NL8401221A (nl) 1984-04-16 1984-04-16 Analytische toepassing van fagocyt-cellijnen.
IL74904A IL74904A (en) 1984-04-16 1985-04-15 Continuous phagocyte cell lines and analytical utilization thereof
US06/723,100 US4737455A (en) 1984-04-16 1985-04-15 Analytical utilization of phagocyte cell lines
DE8585104572T DE3579731D1 (de) 1984-04-16 1985-04-16 Analytische verwendung von phagozyten zellinien.
AT85104572T ATE56750T1 (de) 1984-04-16 1985-04-16 Analytische verwendung von phagozyten zellinien.
EP85104572A EP0159653B1 (de) 1984-04-16 1985-04-16 Analytische Verwendung von phagozyten Zellinien
JP60082106A JPS60256377A (ja) 1984-04-16 1985-04-16 食細胞セルラインの分析への利用

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8401221A NL8401221A (nl) 1984-04-16 1984-04-16 Analytische toepassing van fagocyt-cellijnen.
NL8401221 1984-04-16

Publications (1)

Publication Number Publication Date
NL8401221A true NL8401221A (nl) 1985-11-18

Family

ID=19843814

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8401221A NL8401221A (nl) 1984-04-16 1984-04-16 Analytische toepassing van fagocyt-cellijnen.

Country Status (7)

Country Link
US (1) US4737455A (de)
EP (1) EP0159653B1 (de)
JP (1) JPS60256377A (de)
AT (1) ATE56750T1 (de)
DE (1) DE3579731D1 (de)
IL (1) IL74904A (de)
NL (1) NL8401221A (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894329A (en) * 1987-02-27 1990-01-16 Serono Pharmaceutical Partners Method of assaying the bioactivity of a thymic extract
GB8729661D0 (en) * 1987-12-19 1988-02-03 Univ Dundee Method of determining phagocyte differentiation/activation
WO1990000619A1 (en) * 1988-07-08 1990-01-25 University College London Analysis of cell modifying substances
US5612188A (en) * 1991-11-25 1997-03-18 Cornell Research Foundation, Inc. Automated, multicompartmental cell culture system
US5424216A (en) * 1993-08-16 1995-06-13 Jasco Corporation No radical measuring method and apparatus
US20040053342A1 (en) * 1994-06-08 2004-03-18 Romaschin Alexander D. Measurement of analytes
US6203997B1 (en) 1994-06-08 2001-03-20 Sepsis, Inc. Quantitation of analytes in whole blood
US5804370A (en) * 1994-06-08 1998-09-08 Critichem Medical Products Limited Early diagnosis of sepsis utilizing antigen-antibody interactions amplified by whole blood chemiluminescence
US6306614B1 (en) * 1994-06-08 2001-10-23 Sepsis, Inc. Measurement of analytes in whole blood
ATE280202T1 (de) * 1995-08-25 2004-11-15 Grace Gmbh Antikorrosive pigmente und diese enthaltende zusammensetzungen
US6159683A (en) * 1997-12-16 2000-12-12 Spectral Diagnostics, Inc. Method of determining stage of sepsis
EP1141720A1 (de) * 1998-12-24 2001-10-10 Glaxowellcome B.V. Nachweis von präaktivierten phagozyten
US20030118983A1 (en) * 2000-03-09 2003-06-26 Cassidy Richard A. Rapid screening procedure for inflammation mediators
WO2001066789A1 (en) * 2000-03-09 2001-09-13 U.S. Army Institute Of Surgical Research Rapid screening procedure for inflammation mediators
JP3934605B2 (ja) * 2001-05-31 2007-06-20 扶桑薬品工業株式会社 感染症原因微生物の検出および同定のための改良された方法
US20070059687A1 (en) * 2001-05-31 2007-03-15 Tsuneya Ohno Process for evaluating phagocytotic function and use thereof
US20050129680A1 (en) * 2001-09-17 2005-06-16 Paul Wentworth Antimicrobial activity of antibodies
US20040116350A1 (en) * 2001-09-17 2004-06-17 Paul Wentworth Jr Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
US20030064362A1 (en) * 2001-09-28 2003-04-03 Silver Robert B. Biosensor for detection of toxic substances
DK3404093T3 (da) 2008-07-16 2020-03-16 Childrens Medical Center Anordning og fremgangsmåde til overvågning af celleadfærd
EP2681306B1 (de) 2011-02-28 2019-01-09 President and Fellows of Harvard College Zellkultursystem
US9725687B2 (en) 2011-12-09 2017-08-08 President And Fellows Of Harvard College Integrated human organ-on-chip microphysiological systems
WO2015013332A1 (en) 2013-07-22 2015-01-29 President And Fellows Of Harvard College Microfluidic cartridge assembly
GB2583047B (en) 2013-12-20 2021-03-24 Harvard College Organomimetic devices and methods of use and manufacturing thereof
US11119093B2 (en) 2013-12-20 2021-09-14 President And Fellows Of Harvard College Low shear microfluidic devices and methods of use and manufacturing thereof
GB2546424A (en) 2014-07-14 2017-07-19 Harvard College Systems and methods for improved performance of fluidic and microfluidic systems
WO2017019542A1 (en) 2015-07-24 2017-02-02 President And Fellows Of Harvard College Radial microfluidic devices and methods of use
US12104174B2 (en) 2016-09-13 2024-10-01 President And Fellows Of Harvard College Methods relating to intestinal organ-on-a-chip

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2302747B1 (fr) * 1975-03-03 1978-09-22 Inst Nat Sante Rech Med Procede d'obtention, a partir de macrophages de mammiferes, d'un produit therapeutique actif, notamment, a l'egard des cellules tumorales humaines et produit therapeutique ainsi obtenu
FI64952C (fi) * 1977-06-15 1984-02-10 Wistar Inst Foerfarande foer framstaellning av genetiskt stabila cellinjer
JPS59169492A (ja) * 1983-03-15 1984-09-25 Asahi Chem Ind Co Ltd ヒト融合細胞からの生理活性物質の産生方法

Also Published As

Publication number Publication date
US4737455A (en) 1988-04-12
IL74904A0 (en) 1985-07-31
IL74904A (en) 1989-09-28
DE3579731D1 (de) 1990-10-25
EP0159653A1 (de) 1985-10-30
EP0159653B1 (de) 1990-09-19
JPS60256377A (ja) 1985-12-18
ATE56750T1 (de) 1990-10-15

Similar Documents

Publication Publication Date Title
US4737455A (en) Analytical utilization of phagocyte cell lines
Tschoepe et al. Evidence for abnormal platelet glycoprotein expression in diabetes mellitus
LEVIN et al. Gram-negative sepsis: Detection of endotoxemia with the Limulus test: With studies of associated changes in blood coagulation, serum lipids, and complement
CHRISTOU et al. Neutrophil function in anergic surgical patients: Neutrophil adherence and chemotaxis
Snyderman et al. Deficiency of the fifth component of complement in human subjects: clinical, genetic and immunologic studies in a large kindred
Rasmussen et al. Particulate material as a prerequisite for rapid cell multiplication in Tetrahymena cultures
Bjornson et al. Bacteroidaceae in thromboembolic disease: effects of cell wall components on blood coagulation in vivo and in vitro
SEAMAN Some aspects of phagotrophy in Tetrahymena
Smith et al. Altered megakaryocyte-platelet-haemostatic axis in patients with acute stroke
Rappaport Monolayer Cultures of Trypsinized Monkey Kidney Cells in Synthetic Medium. Application to Poliovirus Synthesis.
Fischer et al. Chemotactically responsive and nonresponsive forms of a continuous human monocyte cell line
Weinberg et al. Phenotypic characterization of gamma interferon-induced human monocyte polykaryons
CN103667174B (zh) 一种用于处理生物样本的组合物
Bayer et al. Circulating immune complexes in experimental streptococcal endocarditis: a monitor of therapeutic efficacy
John Masawe et al. Growth of bacteria in vitro in blood from patients with severe iron deficiency anemia and from patients with sickle cell anemia
Rickles et al. Persistence of group A streptococci labeled with fluorescein isothiocyanate in inflammatory sites in the heart and muscle of mice and rabbits
WO1994017177A1 (en) Methods and kits for determining effects of anti-cancer agents on cancer cells
Scales et al. Development and passive transfer of immunity to gonococcal infection in guinea pigs
McKinney et al. Non-specificity of Thioflavine-T as an Amyloid Stain
Glode et al. Effect of intravenous immune globulin on the coagulopathy of Kawasaki syndrome
Band et al. Observations on induced amitosis in Acanthamoeba
WO1998018320A1 (en) Cell control used to confirm enzymatic activity
ALONSO et al. Phagocytic Activity of Three Naegleria Strains in the Presence of Erythrocytes of Various Types 1
JPH0662834A (ja) 白血球細胞溶解剤を含む微生物標品に関する輸送培地
RU2083661C1 (ru) Штамм бактерий neisseria meningitidis серогруппы с, используемый для получения менингококкового адгезина

Legal Events

Date Code Title Description
A1B A search report has been drawn up
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: INNOGENETICS. N.V. -

BV The patent application has lapsed